ranQ
ranQ
ranQ
DirectoryIndustriesPlacesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The leading AI company directory, built to boost AI visibility.

DEENFRIT
Product
  • Pricing
  • Directory
  • Industries
  • Trust Score
Company
  • About
  • Partner program
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint747,212 companies indexed · Last updated: today
DirectoryIndustryPharmaceutical companyZugNovaBridge Biosciences GmbH
NovaBridge Biosciences GmbH Logo
Verified· 2 sourcesTrust Score
Summary

About the company

NovaBridge Biosciences GmbH is a biotechnology company that identifies drug candidates and advances them through clinical development. Its research focuses include oncology and ophthalmology.

AI-generated
Offering

Products & services

Industry:Pharmaceutical company
✓ Offered3
Oncology Development
Oncology development with Givastomig, Ragistomig and Uliledlimab; bispecific antibodies and a monoclonal antibody for cancer indications.
Ophthalmology Development (Visara)
Ophthalmology development through subsidiary Visara with VIS-101, a VEGF-A/ANG2 bispecific antibody for retinal diseases.
Biotech Partnering and Pipeline Development
Biotech partnering and pipeline development with a global platform, financing and licensing partnerships for innovative medicines.
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
3.7/5

NovaBridge Biosciences GmbH

Trust & reputation

ranQ Trust Score of NovaBridge Biosciences GmbH: 3.7 out of 5.0

Trust Score3.7/ 5.0

Solid

x

Data basis 54% · As of November 2026

NovaBridge Biosciences GmbH has no value in the Reputation area of the ranQ Trust Score because no data is available. The area carries 42% of the weighting and drops out of the calculation for this profile; it does not lower the score, only the reported data basis.
x
CriterionValueWeight
  • Review quality: No data point — the criterion is taken out of the weighting and does not lower the score.—24%
  • Review volume: No data point — the criterion is taken out of the weighting and does not lower the score.—10%
  • Review recency: No data point — the criterion is taken out of the weighting and does not lower the score.—8%
NovaBridge Biosciences GmbH scores 43.9 out of 100 points in the Substance area of the ranQ Trust Score. This area carries 28% of the weighting.
x
CriterionValueWeight
  • Establishment: Years since founding or brand launch, logarithmic. The maximum is reached at 15 years.0.012%
  • Company size: The headcount band, researched by ranQ or stated by the company. It is scored in steps rather than by head count, because the data only provides bands.70.07%
NovaBridge Biosciences GmbH scores 83.3 out of 100 points in the Identity area of the ranQ Trust Score. This area carries 22% of the weighting.
x
CriterionValueWeight
  • Verification: Official register entry (commercial register with UID or professional-body record, 55 points), confirmed domain (20 points) and confirmed ranQ profile (up to 25 points, depending on completeness).83.322%
NovaBridge Biosciences GmbH scores 77.1 out of 100 points in the Visibility area of the ranQ Trust Score. This area carries 8% of the weighting.
x
CriterionValueWeight
  • Website authority: Ahrefs' Domain Rating measures, on a scale of 0 to 100, how strongly a website is linked from other websites. For Swiss SMEs the range up to 40 is typical; the maximum is reached at 35.77.14%
  • Media authority: No data point — the criterion is taken out of the weighting and does not lower the score.—4%
Qualifications+0.00

NovaBridge Biosciences GmbH reaches a ranQ Trust Score of 3.7 out of 5.0 — rated «Solid». No public customer reviews are available for this provider; the rating is based on the remaining criteria. The data basis is 54%, so the score is backed by part of the criteria. As of November 2026.

The Trust Score cannot be bought and is calculated from publicly verifiable data.

Knowledge

No knowledge articles yet

Once NovaBridge Biosciences GmbH has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

NovaBridge Biosciences GmbH in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank NovaBridge Biosciences GmbH by reviews, experience and specialisations.

Is this your company?

Claim the company profile of NovaBridge Biosciences GmbH to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Zählerweg 6
6300 Zug

At a glance

Legal form
Limited Liability Company
UID
CHE-156.621.373
Founded
2026 · 0 years
Last commercial register change
August 19, 2026
Employees
11 to 20
Legal form: Graded by liability and disclosure. The weight is kept small: a sole proprietorship is not a dubious company, it is just liable differently.
88.0
6%
  • Branch offices: Branch offices linked in the commercial register. Having none is normal and costs no points.70.03%
  • Full methodology

    Similar companies

    SI
    Sarepta International Holdings GmbH
    Zug
    NT
    Nektar Therapeutics Europe GmbH
    Zug
    OP
    Orion Pharma AG
    Zug
    BI
    BridgeBio International GmbH
    Zug
    KP
    KalVista Pharmaceuticals Switzerland GmbH
    Zug
    EA
    Elthera AG
    Zug
    CP
    Crinetics Pharmaceuticals Europe GmbH
    Zug
    ST
    Stemline Therapeutics Switzerland GmbH
    Zug